Relation Between Aortic Sclerosis &Severity of Coronary Heart Disease.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Trans thoracic echo doppler.
- Who it may be relevant to
- Registry conditions: Aortic Valve Sclerosis. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Relation Between Aortic Valve Sclerosis and Severity of Coronary Heart Disease Assessed by Syntax Score in Sohag University Hospital
Overview
the goal of the study to identify the relation between aortic valve sclerosis and severity of coronary heart disease by performing transthoracic echo Doppler study for severity of aortic valve sclerosis in patient will undergo coronary angiography with calculation of syntax score as a tool for severity of coronary heart disease.
Interventions
- Diagnostic test Trans thoracic echo doppler
Aortic valve sclerosis severity study be transthoracic echo doppler
Primary outcome measures
- relation between Aortic valve sclerosis and severity of coronary heart disease [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Aortic sclerosis diagnosed by trans thoracic echo doppler
Exclusion criteria
- patients who known to be Rumatic heart disease or congenital aortic valve disease.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-crossover
Study locations
Egypt · 1 center
- Sohag faculty of medicine — Sohag
Identifiers
NCT: NCT06965218 · Soh-Med-25-4___1MD